Figure 1.
ICC-APL-01 study protocol design. 6-MP, 6-mercaptopurine; IDA, idarubicin; MTX, methotrexate; MTZ, mitoxantrone.

ICC-APL-01 study protocol design. 6-MP, 6-mercaptopurine; IDA, idarubicin; MTX, methotrexate; MTZ, mitoxantrone.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal